Sterility in selected cases of deficient spermatogenesis.
For this indication, competent medicine agencies globally authorize below treatments:
Intramuscular
3,000 - 3,000 [iU]
From 3,000 To 3,000 [iU] once every 7 day(s)
Usually, 3,000 IU hCG per week in combination with an FSH or HMG preparation.
This treatment should be continued for at least three months before any improvement in spermatogenesis can be expected. During this treatment testosterone replacement therapy should be suspended. Once achieved, the improvement may sometimes be maintained by hCG alone.
Subcutaneous
3,000 - 3,000 [iU]
From 3,000 To 3,000 [iU] once every 7 day(s)
Usually, 3,000 IU hCG per week in combination with an FSH or HMG preparation.
This treatment should be continued for at least three months before any improvement in spermatogenesis can be expected. During this treatment testosterone replacement therapy should be suspended. Once achieved, the improvement may sometimes be maintained by hCG alone.